
Mylan, the US-based generics specialist, and Biocon, an Indian biopharmaceutical company, have applied for a biologics license application (BLA) for …

Shire Pharmaceuticals is set to pay a $350 million settlement over accusations that it had bribed clinicians and physicians by …

Research conducted by the Sanger Institute in Cambridge has discovered 23 new genes associated with cancer cell’s spread through the …

Rio Galeão, the main airport serving Rio De Janeiro, has been awarded Centre of Excellence for Independent Validators (CEIV) Pharma …

MSD, known as Merck in North America, and Eli Lilly have announced the expansion of their existing immuno-oncology collaboration. The …

MPS has extended its range of child resistant packs. These patented designs offer maximum flexibility and can be customised to …

MSD, known as Merck in North America, has launched a bold move by filing Keytruda, and being accepted, for Priority …

Technology firm Philips and biotech Illumina have announced they are to partner up in collaboration which plans to marry the …

As part of the wider ‘cancer moonshot’ initiative, confirmed by the signing of the 21st Century Cures Act by Obama, …

Japanese pharma firm Daiichi Sankyo has announced its intention to close its R&D centre in Gurgaon, India, a step in …

The FDA regulator has publicly announced that there are safety issues with certain of St. Jude’s medical devices, including cardiac …
Woodley Equipment Company Exhibiting at Summit for Clinical Ops Executives (SCOPE) Woodley Equipment Company is exhibiting at Summit for Clinical …
As a forward-looking company with extensive knowledge and experience, SHL delivers solutions for today on the path to tomorrow. This …

Studies at the Icahn School of Medicine in New York City and the University of Regensburg in Germany have found …

Egalet has gained FDA approval for Arymo ER, a long-acting opioid painkiller that is made to be difficult to breakdown. …

Valeant Pharmaceuticals has announced it is to sell its cancer business Dendreon to Chinese firm Sanpower in a deal worth …

Researchers at King’s College London have discovered a novel use of a drug to treat Alzheimer’s disease, finding that the …

Takeda has acquired US drug maker, Ariad Pharmaceuticals, in a deal worth $5.2 billion. Takeda has been looking to bolster …

It has been announced that the Federal Trade Commission has approved Abbott Laboratories acquisition of St. Jude Medical for $25 …

Happy New Year from us here at Pharmafocus! As we leave 2016 behind, take a look at ten of its …